Goal
Restore insulin independence in type 1 diabetes patients by resetting the immune system
Problem
Autoimmune destruction of pancreatic beta cells requiring lifelong insulin therapy
Concept Summary
The technique removes a patient's own bone-marrow hematopoietic stem cells, uses immunosuppressive drugs to ablate the existing immune system, then reinfuses the stem cells to re-establish immunity. The reset immune system no longer attacks insulin-producing beta cells, allowing endogenous insulin production and insulin independence.
Detailed Description
In the reported clinical protocol, patients receive a short course of cytotoxic immunosuppression (e.g., cytotoxan) and antibiotics while in isolation, followed two an infusion of autologous bone-marrow stem cells via the jugular vein. Immune reconstitution is monitored through blood samples; outcomes are measured by insulin requirement and C-peptide levels. Early results show most participants become insulin-free for months to years, though some experience relapse or complications such as pneumonia or thyroid dysfunction.
Principles
- Autologous stem cell transplantation
- Immune system ablation and reconstitution
- Immunomodulation of auto-reactive T cells
Scientific Domains
Materials
- Bone marrow
- Hematopoietic stem cells
Mechanisms of Action
- Immune system reset
- Elimination of autoreactive T cells
- Regeneration of beta-cell function
Applications
- Treatment of type 1 diabetes
- Potential therapy for other autoimmune diseases
Claimed Performance
12 of 15 patients became insulin-free within days; average follow-up 18 months, one patient 35 months insulin-free. Later study: 6 of 9 patients insulin-free, some up to 3 years.
Experimental Evidence
Clinical trial data reported in JAMA (2009), New Scientist (2007), and PLoS ONE (2012) showing insulin independence in the majority of participants after autologous hematopoietic stem-cell transplantation.
Replication Status
No independent replication reported; results are limited to the original research group.
Limitations
- Small sample size
- Lack of control group
- Risk of infection and other complications from immune ablation
- Variable patient response
Red Flags
- Serious infection risk due to immune system ablation
- Limited independent replication of results
